1464-410X/asset/olbannerleft.gif?v=1&s=3b023a287baccfcd7715cf1935101c4ef9feb906)
1464-410X/asset/olbannerright.gif?v=1&s=2aeadcb16d199baae496a2f637919008651befce)
Laparoscopic and Robotic Urology
You have free access to this content
Visceral obesity is a strong predictor of perioperative outcome in patients undergoing laparoscopic radical nephrectomy
Article first published online: 29 MAY 2012
DOI: 10.1111/j.1464-410X.2012.11274.x
© 2012 BJU INTERNATIONAL
Additional Information
How to Cite
Hagiwara, M., Miyajima, A., Hasegawa, M., Jinzaki, M., Kikuchi, E., Nakagawa, K. and Oya, M. (2012), Visceral obesity is a strong predictor of perioperative outcome in patients undergoing laparoscopic radical nephrectomy. BJU International, 110: E980–E984. doi: 10.1111/j.1464-410X.2012.11274.x
Publication History
- Issue published online: 21 DEC 2012
- Article first published online: 29 MAY 2012
- Accepted for publication 23 March 2012
REFERENCES
- 1, . The obesity epidemic is a worldwide phenomenon. Nutr Rev 1998; 56: 106–14
- 2, , et al. Laparoscopic radical prostatectomy: a multi-institutional study of conversion to open surgery. Urology 2004; 63: 99–102
- 3, , et al. Laparoscopic complications in markedly obese urologic patients (a multi-institutional review). Urology 1996; 48: 562–7
- 4, , , , , . Benefit of laparoscopic radical nephrectomy in patients with a high BMI. Jpn J Clin Oncol 2011; 41: 400–4
- 5, , et al. Laparoscopic nephrectomy: initial case report. J Urol 1991; 146: 278–82
- 6, , , , , . Laparoscopic surgery for stage T1 renal cell carcinoma: radical nephrectomy and wedge resection. Eur Urol 2000; 38: 131–8
- 7, , et al. Transperitoneal nephrectomy for benign disease of the kidney: a comparison of laparoscopic and open surgical techniques. Urology 1994; 43: 607–13
- 8, , et al. Laparoscopic nephrectomy: the experience of the laparoscopy working group of the German Urologic Association. J Urol 1998; 160: 18–21
- 9, . Laparoscopic nephrectomy for renal cell cancer: radical and total. BJU Int 2007; 99: 1251–7
- 10, , , . Laparoscopic nephrectomy: initial experience and cost implications. Br J Urol 1995; 75: 276–80
- 11, , et al. Differences in complications and outcomes for obese patients undergoing laparoscopic radical, partial or simple nephrectomy. J Urol 2004; 172: 2287–91
- 12, , , , . Comparison of open and laparoscopic nephrectomy in obese and nonobese patients: outcomes stratified by body mass index. J Urol 2008; 180: 79–83
- 13, , , , . Laparoscopic radical nephrectomy in obese patients: outcomes and technical considerations. Urology 2004; 63: 247–52; discussion 252
- 14, , , , , . Analysis of impact of body mass index on outcomes of laparoscopic renal surgery. Urology 2007; 69: 38–43
- 15, , , . Benefits of laparoscopic renal surgery are more pronounced in patients with a high body mass index. Eur Urol 2003; 43: 522–7
- 16, . Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881–7
- 17, , . The metabolic syndrome. Lancet 2005; 365: 1415–28
- 18, , , . A novel method of measuring intra-abdominal fat volume using helical computed tomography. Int J Obes Relat Metab Disord 2002; 26: 398–402
- 19, , et al. Assessment of intra-abdominal and subcutaneous abdominal fat: relation between anthropometry and computed tomography. Am J Clin Nutr 1987; 45: 7–13
- 20, , et al. Abdominal fat: standardized technique for measurement at CT. Radiology 1999; 211: 283–6
- 21, , , , . Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001; 91: 421–30
- 22, , , , . Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569–78
- 23, , , , . Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 2006; 17: 901–9
- 24, , , , . Risk factors for renal cell cancer: the multiethnic cohort. Am J Epidemiol 2007; 166: 932–40
- 25
- 26, , et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76–9
- 27, , et al. The influence of obesity on perioperative morbidity: retrospective study of 502 aortocoronary bypass operations. Thorac Cardiovasc Surg 1992; 40: 126–9
- 28, , . A comparison of the perioperative morbidity in total joint arthroplasty in the obese and nonobese patient. Clin Orthop Relat Res 1993; 289: 175–9
- 29, , et al. Adipose tissue distribution and plasma lipoprotein levels in obese women. Importance of intra-abdominal fat. Arteriosclerosis. 1989; 9: 203–10
- 30, , , , . Visceral fat obesity and morbidity: NIDDM and atherogenic risk in Japanese American men and women. Int J Obes 1991; 15 (Suppl. 2): 41–4
- 31, , , . Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987; 36: 54–9
- 32, , et al. Close correlation of intra-abdominal fat accumulation to hypertension in obese women. Hypertension 1990; 16: 484–90
- 33, , et al. Visceral fat accumulation contributes to insulin resistance, small-sized low-density lipoprotein, and progression of coronary artery disease in middle-aged non-obese Japanese men. Jpn Circ J 2001; 65: 193–9
- 34, , , , . Relationship of fat distribution to glucose tolerance. Results of computed tomography in male participants of the Normative Aging Study. Diabetes 1986; 35: 411–5
- 35
- 36
- 37, , et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 1994; 107: 239–46
- 38, , , , , . Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796–808
- 39, . Inflamed fat: what starts the fire? J Clin Invest 2006; 116: 33–5
- 40, . Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347–55
- 41, , , , , . Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 1997; 46: 860–7
- 42. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685–95
- 43. Inflammation and metabolic disorders. Nature 2006; 444: 860–7
- 44, , , . Interferon-gamma is a therapeutic target molecule for prevention of postoperative adhesion formation. Nat Med 2008; 14: 437–41
- 45, . Pathogenesis of postoperative adhesion formation. Br J Surg 2011; 98: 1503–16
- 46, , et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 2010; 58: 398–406